Haining Yang

7PUBLICATIONS
28CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)MechanobiologyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 23, 2026
HMGB1 directly activates BAP1 transcription to sustain tumor growth in mesothelioma.

|Jul 11, 2024
Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling.

Flavia Novelli, Yoshie Yoshikawa, Veronica Angela Maria Vitto

|Sep 20, 2023
HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma.

Joelle S Suarez, Flavia Novelli, Keisuke Goto

|Jan 19, 2023
BAP1 is a novel regulator of HIF-1α.

Angela Bononi, Qian Wang, Alicia A Zolondick

|Dec 15, 2020
Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma.

Angela Bononi, Keisuke Goto, Guntulu Ak

|Oct 27, 2020
HMGB1 as a therapeutic target in disease.

Jiaming Xue, Joelle S Suarez, Michael Minaai

Pageof 2

Frequent Collaborators

6 joint publications

Joelle Suarez

5 joint publications

Michele Carbone

5 joint publications

Flavia Novelli

5 joint publications

Ronghui Xu